Alzheimer’s Disease and Related Disorders: Treatment Strategies

 

Alzheimer's disease (AD) is a progressive neurodegenerative disease that gradually worsens over time. The hallmark feature of AD is cognitive impairment such as memory loss, communication difficulties, impaired judgement, and confusion resulting in a decline in functional ability as well as behavioral and personality changes. Caring for persons with cognitive impairments is complex and multifaceted, with every person with AD having a different plan of care based on their needs, preferences, and abilities, and this plan sometimes needing to change from day to day. The goal of care for the person with AD is to help the individual maintain functional ability for as long as possible and improve quality of life. Critical to obtaining this goal is the use of pharmacologic treatments to help slow down the progression of cognitive symptoms. This course will review the different treatments available for Alzheimer’s disease, as well as recent research on the effectiveness of the medications that are available, new advances into the treatment of the disease, and alternative treatments that may be used.

$20.00

Hours: 1.00
REL-SRC-0-ADRDTS

Certificates

Certificates provided by accrediting body (17 Match)

Georgia Nursing Home Administrators Board

1.0 HOURS


Course approved by the Georgia Nursing Home Administrators Board.
Provider # 50-290
This activity is approved for 1.00 contact hours.

California Nursing Home Administrator Program - P type

1.0 HOURS


This educational offering is approved by the California Nursing Home Administrator Program (NHAP) as a Patient Care/Aging ("P" credit) course. Provider # CEP 1701; Course Approval # 1701001-6281/P. This activity is approved for 1.00 contact hours.

Florida Board of Nursing Home Administrators

1.0 HOURS


Course approved by the Florida Board of Nursing Home Administrators.
Provider # 50-290
NHA/RCAL
This activity is approved for 1.00 contact hours.

Missouri Health Care Association

1.0 HOURS


This on-line activity has been approved for 1.00 Patient Care Hour(s) toward the Missouri continuing education requirement for nursing home administrators. Relias LLC offers courses approved by the Missouri Health Care Association, an approved training agency, TA-002-919, by the Missouri Board of Nursing Home Administrators. This activity is approved for 1.00 contact hours.

Tennessee Department of Health

1.0 HOURS


Learning activity approved by the Tennessee Department of Health, Bureau of Health Licensure and Regulation as continuing education for Residential Homes for the Aged and Assisted Care Living Facility administrators. This activity is approved for 1.00 contact hours.

California Board of Registered Nursing

1.0 HOURS


Provider approved by the California Board of Registered Nursing, CEP# 13791

Nurses will receive 1.00 contact hours for participating in this course.

District of Columbia Board of Nursing

1.0 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 1.00 contact hours for participating in this course.

Florida Board of Nursing

1.0 HOURS


Florida Board of Nursing CE Provider #: 50-290

Nurses will receive 1.00 contact hours for participating in this course.

American Nurses Credentialing Center

1.0 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 1.00 contact hours for participating in this course.

Georgia Board of Nursing

1.0 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 1.00 contact hours for participating in this course.

South Carolina Board of Nursing

1.0 HOURS


This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]

North Carolina Department of Health and Human Services Division of Facility Services

1.0 HOURS


This course is approved by the North Carolina Department of Health and Human Services Division of Facility Services - Group Care Licensure Section (NC-DHHS)
Program Sponsor ID #032316; Approval # . This activity is approved for 1.00 contact hours.

National Association of Long Term Care Administrator Boards (RCAL)

1.0 HOURS


This educational offering has been reviewed by the National Continuing Education Review Service (NCERS) of the National Association of Long Term Care Administrator Boards (NAB) and approved for 1.00 clock hours. If you have any feedback regarding the NAB approved continuing education programs, send your email to the following address: [email protected]

Oregon Department of Human Services

1.0 HOURS


This course is approved as continuing education by the Oregon Department of Human Services in accordance with state regulation 411-057-0140 for Assisted Living Administrators, Residential Care facility Administrators and Memory Care Communities within the State of Oregon. This activity is approved by Oregon Department of Human Services for 1.00 contact hours.

National Association of Long Term Care Administrator Boards (NHA)

1.0 HOURS


This educational offering has been reviewed by the National Continuing Education Review Service (NCERS) of the National Association of Long Term Care Administrator Boards (NAB) and approved for 1.00 clock hours. If you have any feedback regarding the NAB approved continuing education programs, send your email to the following address: [email protected]
Hours type - NHA: Resident Care

West Virginia Board of Registered Nursing

1.0 HOURS


National Certification Council for Activity Professionals

1.0 HOURS


This course is NCCAP approved NCCAP500270-20NT. All NCCAP approved courses count 100% towards certification.

Course Details

Course Code: REL-SRC-0-ADRDTS
Hours: 1
Type: Online Course
Content Expiration Date: 8/31/2020
Learning Objectives:
Describe the mode of action, dosing considerations, precautions, and adverse reactions of medications commonly prescribed to treat Alzheimer’s disease.
Identify alternative treatments for Alzheimer’s disease.
Describe new advances into Alzheimer’s disease treatment.
Outline the pharmacological treatment for depression occurring in individuals with Alzheimer’s disease.

Outline:
Section 1: Introduction A. About This Course B. Learning Objectives Section 2: Pharmacologic Treatment of AD A. A Quick Review B. Cholinesterase Inhibitors C. Dosing Considerations D. Galantamine Dosing E. Rivastigmine Dosing F. Donepezil Dosing G. Warnings and Precautions H. Adverse Reactions I. NMDA Receptors J. Memantine Action and Dosing K. Memantine Warnings and Precautions L. Memantine/Donepezil M. Review N. Summary Section 3: Alternative Treatments for AD A. Herbal Remedies B. Caprylic Acid C. Coenzyme Q10 D. Ginkgo Biloba E. Coral Calcium F. Acupuncture and Acupressure G. Aromatherapy H. Yoga I. Diet J. Review K. Summary Section 4: Current Research and Advancements for AD A. A Future Without Alzheimer’s Disease B. Solanezumab C. Verubecestat D. AADvac1 E. CSP-1103 F. Intepirdine G. Review H. Summary Section 5: Treating Depression A. Antidepressants B. Citalopram C. Escitalopram D. Fluoxetine E. Antipsychotics F. Review G. Summary Section 5: Conclusion A. Summary B. Course Contributor C. References D. Congratulations!

Instructor: Jessica Cairns, RN, RAC-CT, CMAC
Jessica has almost 15 years of experience in nursing and 10 years in MDS/PAC working with organizations for the purposes of assessment, reimbursement, training, organizational, and leadership development. In these roles, she has acted as a consultant and auditor. Jessica has written content for diverse healthcare topics, including health and human services, compliance and more. Disclosure: Jessica Cairns, RN, RAC-CT, CMAC has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: entry and intermediate level Nurses; entry level Administrators; in the following settings: Post-Acute Care.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.